[1] |
Gao J, Prasad N. Chronic obstructive pulmonary disease in China: the potential role of indacaterol[J]. J Thorac Dis, 2013, 5(4):549-558.
|
[2] |
Choudhury G, Rabinovich R, MacNee W. Comorbidities and systemic effects of chronic obstructive pulmonary disease[J]. Clin Chest Med, 2014, 35(1):101-130.
|
[3] |
Wang C, Xu JY, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study[J]. Lancet, 2018, 391(10131):1706-1717.
|
[4] |
Hrdlickova B, Almeida RCD, Borek Z, et al. Genetic variation in the non-coding genome: Involvement of micro-RNAs and long non-coding RNAs in disease[J]. Biochim Biophys Acta, 2014, 1842(10):1910-1922.
|
[5] |
Li F, Zhang L, Li W, et al. Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathway[J]. Oncotarget, 2015, 6(8):6001-6013.
|
[6] |
Wang K, Long B, Liu F, et al. A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223[J]. Eur Heart J, 2016, 37(33):2602-2611.
|
[7] |
Kara M, Kirkil G, Kalemci S. Differential expression of microRNAs in chronic obstructive pulmonary disease[J]. Adv Clin Exp Med, 2016, 25(1):21-26.
|
[8] |
Turino GM, Ma S, Cantor JO, et al. Biomarkers in alpha-1 antitrypsin deficiency chronic obstructive pulmonary disease[J]. Ann Am Thorac Soc, 2016, 13 Suppl 4:S336-S340.
|
[9] |
Akbas F, Coskunpinar E, Aynacl E, et al. Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease[J]. Exp Lung Res, 2012, 38(6):286-294.
|
[10] |
Soeda S, Ohyashiki JH, Ohtsuki K, et al. Clinical relevance of plasma miR-106b levels in patients with chronic obstructive pulmonary disease[J]. Int J Mol Med, 2013, 31(3):533-539.
|
[11] |
Leidinger P, Keller A, Borries A, et al. Specific peripheral miRNA profiles for distinguishing lung cancer from COPD[J]. Lung Cancer, 2011, 74(1):41-47.
|
[12] |
Westholm JO, Miura P, Olson S, et al. Genome-wide analysis of drosophila circular RNAs reveals their structural and sequence properties and age-dependent neural accumulation[J]. Cell Rep, 2014, 9(5):1966-1980.
|
[13] |
Bahn JH, Zhang Q, Li F, et al. The landscape of microRNA, piwi-interacting RNA, and circular RNA in human saliva[J]. Clin Chem, 2015, 61(1):221-230.
|
[14] |
Li Y, Zheng Q, Bao C, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis[J]. Cell Res, 2015, 25(8):981-984.
|
[15] |
Kulcheski FR, Christoff AP, Margis R. Circular RNAs are miRNA sponges and can be used as a new class of biomarker[J]. J Biotechnol, 2016, 238(12):42-51.
|